Reaction Details Report a problem with these data
Target
cAMP-specific 3',5'-cyclic phosphodiesterase 4B
Ligand
BDBM50017313
Substrate
n/a
Meas. Tech.
ChEMBL_1362418 (CHEMBL3292526)
IC50
0.019953±n/a nM
Citation
 De Savi, C; Cox, RJ; Warner, DJ; Cook, AR; Dickinson, MR; McDonough, A; Morrill, LC; Parker, B; Andrews, G; Young, SS; Gilmour, PS; Riley, R; Dearman, MS Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD. J Med Chem 57:4661-76 (2014) [PubMed]  Article 
Target
Name:
cAMP-specific 3',5'-cyclic phosphodiesterase 4B
Synonyms:
3',5'-cyclic phosphodiesterase | DPDE4 | Isoform PDE4B1 | PDE32 | PDE4B | PDE4B1 | PDE4B_HUMAN | Phosphodiesterase 4B | Phosphodiesterase 4B (PDE4B) | Phosphodiesterase 4B (PDE4B1) | Phosphodiesterase Type 4 (PDE4B)
Type:
Protein
Mol. Mass.:
83318.87
Organism:
Homo sapiens (Human)
Description:
Q07343
Residue:
736
Sequence:
MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT
  
Inhibitor
Name:
BDBM50017313
Synonyms:
CHEMBL3287999
Type:
Small organic molecule
Emp. Form.:
C38H38F2N6O5
Mol. Mass.:
696.7423
SMILES:
Oc1ccc(c(CN2CCCOCC2)c1)-c1cccc(Oc2ncc(F)cc2C(=O)N[C@@H]2CC[C@@H](CC2)NC(=O)c2cn3cc(F)ccc3n2)c1 |r,wU:34.40,31.33,(13.4,-36.59,;12.06,-35.83,;10.73,-36.61,;9.39,-35.85,;9.39,-34.3,;10.71,-33.52,;10.7,-31.98,;12.02,-31.2,;11.9,-29.67,;13.02,-28.62,;14.54,-28.83,;15.32,-30.15,;14.77,-31.59,;13.3,-32.06,;12.05,-34.28,;8.05,-33.54,;6.71,-34.32,;5.38,-33.55,;5.38,-32.01,;6.71,-31.24,;6.71,-29.7,;5.37,-28.93,;4.04,-29.71,;2.69,-28.93,;2.7,-27.38,;1.36,-26.62,;4.03,-26.62,;5.37,-27.38,;6.7,-26.61,;6.69,-25.06,;8.04,-27.37,;9.37,-26.6,;10.71,-27.37,;12.03,-26.6,;12.04,-25.06,;10.7,-24.29,;9.36,-25.06,;13.38,-24.29,;14.71,-25.06,;14.71,-26.6,;15.93,-24.11,;15.88,-22.59,;17.33,-22.07,;17.91,-20.65,;19.42,-20.44,;20,-19.02,;20.37,-21.66,;19.79,-23.08,;18.27,-23.28,;17.41,-24.56,;8.04,-32,)|
Structure:
Search PDB for entries with ligand similarity: